Institute of Translational of Medicine, Institute of immunology and immunotherapy and NIHR Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, UK; Department of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada.
Institute of Translational of Medicine, Institute of immunology and immunotherapy and NIHR Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, UK; Department of Gastroenterology, Spedali Civili of Brescia, Italy.
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):598-606. doi: 10.1016/S2468-1253(20)30119-9. Epub 2020 Apr 16.
The coronavirus disease 2019 (COVID-19) pandemic is changing the management of many chronic diseases, including that of patients with inflammatory bowel diseases (IBD). In particular, the performance of routine endoscopy is temporarily suspended, and only emergency endoscopy is allowed in many countries where severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread. We highlight different scenarios in which endoscopy should still be performed urgently in patients with IBD, as well as recommendations regarding the use of personal protective equipment. We suggest a pathway for performing safe endoscopy and discuss the potential risks of postponing endoscopy in IBD. Finally, we propose a post-pandemic plan for access to endoscopy.
新型冠状病毒病 2019（COVID-19）大流行正在改变许多慢性疾病的管理方式，包括炎症性肠病（IBD）患者的管理方式。特别是在严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）传播的许多国家，常规内镜检查暂时停止，只允许进行紧急内镜检查。我们强调了在 IBD 患者中仍应紧急进行内镜检查的不同情况，以及关于个人防护设备使用的建议。我们建议了进行安全内镜检查的途径，并讨论了延迟 IBD 内镜检查的潜在风险。最后，我们提出了一个内镜检查的后疫情计划。
